Chroma Medicine is pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, revolutionizing the treatment of genetically driven diseases.
The epigenome is nature’s gatekeeper for gene expression, governing cell phenotype and function by precisely controlling gene activity without changing the underlying DNA sequence. Building on groundbreaking research from the world’s foremost genomic medicine experts, Chroma Medicine is working at the cutting edge of precision genomics, building an entirely new class of therapeutics to achieve unparalleled control of gene expression.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $260M
Founded date: 2021
Investors 5
| Date | Name | Website |
| 21.02.2023 | DCVC | dcvc.com/ |
| 08.11.2023 | ARCH Ventu... | archventur... |
| 15.01.2022 | Omega Fund... | omegafunds... |
| 18.11.2021 | Atlas Vent... | atlasventu... |
| - | Newpath Ma... | newpath.pa... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 01.03.2023 | Series B | $135M | Janus Hend... | finsmes.co... |
| 17.11.2021 | - | $125M | - | marketscre... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 01.03.2023 | Chroma Medicine Raises $135M in Series B Financing | Chroma Medicine, a Cambridge, MA-based genomic medicine company, raised $135M in Series B funding. ... | finsmes.co... |
| 01.03.2023 | Chroma Medicine Secures $135M in Series B | CAMBRIDGE, MA, Chroma Medicine announces the completion of a $135 million Series B financing led b... | vcnewsdail... |
| 19.11.2021 | Neo-bank Dave’s CEO thinks traditional banks are ‘in a pickl... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 19.11.2021 | Neo-bank Dave’s CEO thinks traditional banks are ‘in a pickl... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 17.11.2021 | Chroma Medicine Launches with $125M in Financing to Deliver ... | CAMBRIDGE, Mass., Nov. 17, 2021 /PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a new genomic medici... | marketscre... |
| - | Chroma Medicine | “Chroma Medicine is pioneering a new class of epigenetic medicines to revolutionize treatment of gen... | fastfounde... |